US Patent Issued to Shin Nippon Biomedical Laboratories on Nov. 25 for "Powder formulation for intranasal administration, and manufacturing method thereof" (Japanese Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,581, issued on Nov. 25, was assigned to Shin Nippon Biomedical Laboratories Ltd. (Kagoshima, Japan).

"Powder formulation for intranasal administration, and manufacturing method thereof" was invented by Shunji Haruta (Kagoshima, Japan) and Yo Sonoda (Kagoshima, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "An object of the present invention is to provide a powder formulation for intranasal administration, which efficiently exhibits a medicinal effect, and the like. The object can be achieved by a powder formulation for intranasal administration comprising composite particles in which an active ingredient and a water-insoluble polysaccharide ar...